Drug intelligence / Profile preview

geniposide

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Geniposide is a bioactive iridoid glycoside primarily extracted from the fruit of Gardenia jasminoides. It is considered the glycosylated form of genipin and is a major active component responsible for many pharmacological effects attributed to traditional herbal medicines containing gardenia. Geniposide exhibits diverse biological activities, including neuroprotective, antidiabetic, hepatoprotective, anti-inflammatory, analgesic, antidepressant-like, cardioprotective, antioxidant, immune-regulatory, antithrombotic and antitumoral effects[1][3][4]. Mechanistically, it acts as an agonist at the glucagon-like peptide-1 receptor (GLP-1R), which underlies its neuroprotective and metabolic benefits such as enhanced insulin secretion and β-cell protection[1][3][4]. It also modulates inflammatory pathways (e.g., NF-kB/MAPK/TLR4) and may regulate mTOR signaling to promote autophagy in neurodegenerative disease models[6]. Geniposide has been studied for potential therapeutic roles in diabetes mellitus (improving glucose utilization/insulin production), liver diseases (hepatoprotection), cardiovascular diseases (cardioprotection), Alzheimer’s disease and Parkinson’s disease (neuroprotection)[3][6].

Other names
geniposidicGenipin 1-glucosideGenipin1-glucosideGenipin-1-glucosideJasminoidin
02

Targets

GLP1R (GLP-1R)NF-κBTLR4 (Toll-like receptor 4)MEK

Beyond the preview

Go deeper on geniposide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on geniposide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call